Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001
Titel:
Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001
Auteur:
Hamid, O. Robert, C. Daud, A. Hodi, F.S. Hwu, W.J. Kefford, R. Wolchok, J.D. Hersey, P. Joseph, R. Weber, J.S. Dronca, R. Mitchell, T.C. Patnaik, A. Zarour, H.M. Joshua, A.M. Zhao, Q. Jensen, E. Ahsan, S. Ibrahim, N. Ribas, A.